SOCS3 modulates the response to enzalutamide and is regulated by androgen receptor signaling and CpG methylation in prostate cancer cells

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • F. Handle - , Innsbruck Medical University (Author)
  • Holger H.H. Erb - , Innsbruck Medical University, University of York (Author)
  • Birgit Luef - , Innsbruck Medical University (Author)
  • Julia Hoefer - , Innsbruck Medical University (Author)
  • Dimo Dietrich - , University of Bonn Medical Center (Author)
  • Walter Parson - , Innsbruck Medical University, Pennsylvania State University (Author)
  • Glen Kristiansen - , University of Bonn Medical Center (Author)
  • F.R. Santer - , Innsbruck Medical University (Author)
  • Z. Culig - , Innsbruck Medical University (Author)

Details

Original languageEnglish
Pages (from-to)574–585
JournalMolecular cancer research : MCR
Volume14
Issue number6
Publication statusPublished - Jun 2016
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 27053681
ORCID /0000-0001-5209-7914/work/96250350
Scopus 84975081946

Keywords

Sustainable Development Goals